Pure Global AI
NCT06346678Not yet recruiting

Accuracy of Accuhaler Tester, Ellipta Tester and Turbutester in Patients With Chronic Obstructive Pulmonary Disease

Thammasat UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Chronic Obstructive Pulmonary Disease
Drug/Device/Intervention
Accuhaler tester
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Thammasat University
Timeline & enrollment
Phase
N/A
Start date
Apr 16, 2024
End date
Oct 31, 2024
Enrollment
80 participants
Primary outcome

Accuracy of Accuhaler tester,Accuracy of Ellipta tester,Accuracy of Turbutester

Summary

The goal of this observational study is to investigate the accuracy of Accuhaler tester,
 Ellipta tester and Turbutester in patients with chronic obstructive pulmonary disease (COPD).
 The main question it aims to answer is:
 
 • Do Accuhaler tester, Ellipta tester, and Turbutester demonstrate comparable accuracy to the
 In-check DIAL for assessing inspiratory inhalation force in COPD patients?

ICD-10 classifications
Other chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06346678
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06346678 through Pure Global AI's free database. This phase not specified trial is sponsored by Thammasat University and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.